Viewing StudyNCT00111449



Ignite Creation Date: 2024-05-05 @ 11:44 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00111449
Status: COMPLETED
Last Update Posted: 2013-05-15
First Post: 2005-05-20

Brief Title: Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis
Sponsor: Amgen
Organization: Amgen

Conditions & Keywords Data

Conditions:
Name
Psoriasis
Keywords:
Name View
moderate severe View
Psoriasis adults View
skin Phase 3 View
clinical trial Amgen View
etanercept Enbrel View